title: [Hyperkalemia: the new killer?].
abstract: Hyperkalemia is now commonly observed due to several associated factors such as old age, diabetes, congestive heart failure, renal insufficiency and drugs such as spironolactone used to improve cardiac function. Moreover, the easily prescribed new antiinflammatory drugs COX2 selective inhibitors in these patients lead to a very acute risk for vital hyperkalemia development. This review insists on the prevention of such potentially reversible disorder.
authors.affiliation: Service de Néphrologie, CHU Sart Tilman, 4000 Liège.
authors.forename: J M
authors.initials: JM
authors.lastname: Krzesinski
mesh_terms: D006801:Humans; D006947:Hyperkalemia / Q000209:etiology*; D012307:Risk Factors